OTCMKTS:EUCRU Eucrates Biomedical Acquisition (EUCRU) Stock Price, News & Analysis $10.02 +0.01 (+0.10%) As of 04/26/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Eucrates Biomedical Acquisition Stock (OTCMKTS:EUCRU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EUCRU alerts:Sign Up Key Stats Today's Range$10.01▼$10.0250-Day Range$10.02▼$10.0252-Week Range$9.76▼$10.66Volume21,500 shsAverage Volume1,921 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Read More… Receive EUCRU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eucrates Biomedical Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address EUCRU Stock News HeadlinesPsyence Biomed halts Clairvoyant Therapeutics acquisitionOctober 6, 2024 | investing.comEucrates Biomedical Acquisition announces liquidationApril 11, 2023 | seekingalpha.comWhat is Warren Buffett Hiding?Warren Buffett just poured $40 billion into one quiet sector—and now investors are calling this dividend play the “last retirement stock you’ll ever need.” It’s not a tech company or AI darling. But it’s raking in cash and paying a nearly 8% dividend—even as the broader market stumbles.May 18, 2025 | Behind the Markets (Ad)Eucrates Biomedical Acquisition Corp. Announces LiquidationApril 11, 2023 | finance.yahoo.comBiomedical Sensors Market will surpass USD 21.3 billion by 2030 at a CAGR of 16% till 2030 : GreyViewsJanuary 30, 2023 | finance.yahoo.comLove Island 2023: First contestant revealed as stunning biomedical student TanyaJanuary 25, 2023 | mirror.co.ukBiomedical EngineerJanuary 11, 2023 | money.usnews.comCenterline Biomedical announces Gulam Khan as Chief Executive OfficerOctober 6, 2022 | markets.businessinsider.comSee More Headlines EUCRU Stock Analysis - Frequently Asked Questions How have EUCRU shares performed this year? Eucrates Biomedical Acquisition's stock was trading at $10.02 at the beginning of 2025. Since then, EUCRU shares have increased by 0.0% and is now trading at $10.02. View the best growth stocks for 2025 here. How do I buy shares of Eucrates Biomedical Acquisition? Shares of EUCRU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Shell Companies Sub-IndustryTrading Current SymbolOTCMKTS:EUCRU CIK1822929 WebN/A Phone(212) 710-5220FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:EUCRU) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eucrates Biomedical Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eucrates Biomedical Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EUCRU Stock Free EUCRU Stock Alerts